PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity
- Resource Type
- Article
- Source
- In
Drug Resistance Updates May 2023 68 - Subject
- Language
- ISSN
- 1368-7646